This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Pharma Kg. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Eric Haaksma: Innovator in Antithrombotic Research
Introduction
Eric Haaksma is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antithrombotic agents. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Eric Haaksma holds a patent for "Antithrombotic phenylalkyl derivatives." This innovative patent focuses on the formulation of antithrombotic phenylalkyl derivatives of a specific chemical structure. His research in this area has the potential to impact the treatment of thrombotic disorders significantly.
Career Highlights
Haaksma is currently employed at Boehringer Ingelheim Pharma KG, a leading global pharmaceutical company. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects.
Collaborations
Throughout his career, Eric has worked alongside esteemed colleagues such as Rainer Soyka and Armin Heckel. These collaborations have fostered an environment of innovation and have led to advancements in pharmaceutical research.
Conclusion
Eric Haaksma's contributions to antithrombotic research exemplify the impact of dedicated inventors in the pharmaceutical industry. His patent and ongoing work at Boehringer Ingelheim Pharma KG highlight the importance of innovation in improving healthcare solutions.